← Leaderboards
Nigel Key
Univ Of North Carolina Chapel Hill
$421,820
Attributed
$421,820
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $182.5K · FY2008–12$200K$150K$100K$50K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$421,820 · 2
By mechanism
U01$421,590 · 1
M01$230 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Chengwen Li$10,504,911
- Richard J Samulski$19,583,832
- Stefanie Sarantopoulos$7,871,947
- Aaron L Fogelson$5,408,600
- Gianpietro Dotti$17,018,250
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingResourcesResearch PersonnelLaboratoriesMeetingsMulti-Institutional Clinical TrialNational Heart, Lung, And Blood InstituteAdultMedicalLeadChildData Coordinating CenterClinical TrialsAreaCollaborationsIntentionBloodHemostatic FunctionClinical Trials NetworkFutureConduct Clinical TrialsHematologyCytokine TherapyHemostatic Agents
Grant awards (4)
Transfusion Medicine/Hemostasis Clinical Trials Network$159,688
U01 · FY2012 · HL · contact PI
Transfusion Medicine/Hemostasis Clinical Trials Network$79,402
U01 · FY2010 · HL · contact PI
Transfusion Medicine/Hemostasis Clinical Trials Network$182,500
U01 · FY2009 · HL · contact PI
RITUXIMAB FOR THE TREATMENT OF INHIBITORS IN CONGENITAL HEMOPHILIA A$230
M01 · FY2008 · RR · contact PI